In Reply to Belkacemi and Tsoutsou.

Auteurs : Zeidan YH, Habib JG, de Azambuja E, Campbell I, Andersson M, Lluch A, Di Leo A, Francis PA
Jaar : 2018
Journal : Int J Radiat Oncol Biol Phys
Volume : 102
Pagina's : 467-468

CDK4/6 inhibitors in the treatment of patients with breast cancer: summary of a multidisciplinary round-table discussion.

Auteurs : Preusser M, De Mattos-Arruda L, Thill M, Criscitiello C, Bartsch R, Ruhstaller T, de Azambuja E, Zielinski CC
Jaar : 2018
Journal : ESMO Open
Volume : 3
Pagina's : e000368

Quality management for systemic treatment of breast cancer

Auteurs : Verhoeven D, Duhoux FP, de Azambuja E, Wildiers H, Vuylsteke P, Barbeaux A, Van Damme N, Van Eycken E
Jaar : 2018
Journal : Belgian J Medical Oncology
Volume : 11(1)
Pagina's : 15-21

Breast cancer and pregnancy-related issues.

Auteurs : Lambertini M, Nguyen B, Viglietti G, Martel S, de Azambuja E
Jaar : 2018
Journal : Belgian J Medical Oncology
Volume : 11(1)
Pagina's : 9-14

Pharmacologic measures in the prevention of left ventricular dysfunction associated with molecular-targeted therapies in the treatment of cancer patients.

Auteurs : Awada G, de Azambuja E, Awada A
Jaar : 2017
Journal : Expert Opin Drug Metab Toxicol
Volume : 13(12)
Pagina's : 1205-1215

Recurrence dynamics of breast cancer according to baseline body mass index.

Auteurs : Biganzoli E, Desmedt C, Fornili M, de Azambuja E, Cornez N, Ries F, Closon-Dejardin MT, Kerger J, Focan C, Di Leo A, Nogaret JM, Sotiriou C, Piccart-Gebhart M, Demicheli R
Jaar : 2017
Journal : Eur J Cancer
Volume : 87
Pagina's : 10-20

11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial.

Auteurs : Cameron D, Piccart-Gebhart M, Gelber Rd, Procter M, Goldhirsch A, de Azambuja E, Castro G Jr, Untch M, Smith I, Gianni L, Baselga J, Al-Sakaff N, Lauer S, Mcfadden E, Leyland-Jones B, Bell R, Dowsett M, Jackisch C
Jaar : 2017
Journal : Lancet
Volume : 389(10075)
Pagina's : 1195-1205

The prognostic role of androgen receptor in patients with early stage breast cancer: A meta-analysis of clinical and gene expression data.

Auteurs : Bozovic-Spasojevic I, Zardavas D, Brohée S, Ameye L, Fumagalli D, Ades F, de Azambuja E, Bareche Y, Piccart-Gebhart M, Paesmans M, Sotiriou C
Jaar : 2017
Journal : Clin Cancer Res
Volume : 23(11)
Pagina's : 2702-2712

Adjuvant trastuzumab: a 10-year overview of its benefit.

Auteurs : Lambertini M, Pondé NF, Solinas C, de Azambuja E
Jaar : 2017
Journal : Expert Rev Anticancer Ther
Volume : 17
Pagina's : 61-74

RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy: A Secondary Analysis of the NeoALTTO Randomized Clinical Trial.

Auteurs : Fumagalli D, Venet D, Ignatiadis M, Azim HA Jr, Maetens M, Rothé F, Salgado R, Bradbury I, Pusztai L, Harbeck N, Gomez H, Chang TW, Coccia-Portugal MA, Di Cosimo S, de Azambuja E, de la Peña L, Nuciforo P, Brase JC, Huober J, Baselga J, Piccart-Gebhart M, Loi S, Sotiriou C
Jaar : 2017
Journal : JAMA Oncol
Volume : 3
Pagina's : 227-234

Impact of Diabetes, Insulin, and Metformin Use on the Outcome of Patients With Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Analysis From the ALTTO Phase III Randomized Trial.

Auteurs : Sonnenblick A, Agbor-Tarh D, Bradbury I, Di Cosimo S, Azim HA Jr, Fumagalli D, Sarp S, Wolff AC, Andersson M, Kroep J, Cufer T, Simon SD, Salman P, Toi M, Harris L, Gralow J, Keane M, Moreno-Aspitia A, Piccart-Gebhart M, de Azambuja E
Jaar : 2017
Journal : J Clin Oncol
Volume : 35
Pagina's : 1421-1429

Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.

Auteurs : Gingras I, Holmes E, de Azambuja E, Nguyen DH, Izquierdo M, Anne Zujewski J, Inbar M, Naume B, Tomasello G, Gralow JR, Wolff AC, Harris L, Gnant M, Moreno-Aspitia A, Piccart-Gebhart M, Azim HA Jr
Jaar : 2017
Journal : J Natl Cancer Inst
Volume : 109

Professional Burnout in European Young Oncologists: Results of The European Society For Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey.

Auteurs : Banerjee S, Califano R, Corral J, de Azambuja E, De Mattos-Arruda L, Guarneri V, Hutka M, Jordan K, Martinelli E, Mountzios G, Ozturk MA, Petrova M, Postel-Vinay S, Preusser M, Qvortrup C, Volkov MNM, Tabernero J, Olmos D, Strijbos MH
Jaar : 2017
Journal : Ann Oncol
Volume : 28(7)
Pagina's : 1590-1596

Are life-saving anticancer drugs reaching all patients? Patterns and discrepancies of trastuzumab use in the European Union and the USA.

Auteurs : Ades F, Senterre C, Zardavas D, de Azambuja E, Popescu R, Piccart-Gebhart M
Jaar : 2017
Journal : PLoS One
Volume : 12(3)
Pagina's : e0172351

Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Stu

Auteurs : Zardavas D, Suter TM, van Veldhuisen DJ, Steinseifer J, Noe J, Lauer S, Al-Sakaff N, Piccart-Gebhart M, de Azambuja E
Jaar : 2017
Journal : J Clin Oncol
Volume : 35(8)
Pagina's : 878-884

Ovarian Function Suppression in Premenopausal Women with Early-Stage Breast Cancer.

Auteurs : Lambertini M, Del Mastro L, Viglietti G, Pondé NF, Solinas C, de Azambuja E
Jaar : 2017
Journal : Curr Treat Options Oncol
Volume : 18
Pagina's : 4

Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.

Auteurs : Von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber Rd, Piccart-Gebhart M, Baselga J
Jaar : 2017
Journal : N Engl J Med
Volume : 377(2)
Pagina's : 122-131

Tumor-infiltrating lymphocytes in patients with HER2-positive breast cancer treated with neoadjuvant chemotherapy plus trastuzumab, lapatinib or their combination: A meta-analysis of randomized controlled trials.

Auteurs : Solinas C, Ceppi M, Lambertini M, Scartozzi M, Buisseret L, Garaud S, Fumagalli D, de Azambuja E, Salgado R, Sotiriou C, Willard-Gallo K, Ignatiadis M
Jaar : 2017
Journal : Cancer Treat Rev
Volume : 57
Pagina's : 8-15

EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours.

Auteurs : Le Rhun E, Weller M, Brandsma D, Van den Bent M, de Azambuja E, Henriksson R, Boulanger T, Peters S, Watts C, Wick W, Wesseling P, Rudà R, Preusser M
Jaar : 2017
Journal : Ann Oncol
Volume : 28
Pagina's : iv84-iv99

HER2-positive breast cancer is lost in translation: time for patient-centered research.

Auteurs : Gingras I, Gebhart G, de Azambuja E, Piccart-Gebhart M
Jaar : 2017
Journal : Nat Rev Clin Oncol
Volume : 14(11)
Pagina's : 669-681